Compare FinCanna Capital (FNNZF) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

FinCanna Capital (FNNZF)

Price

$0.00

Change

+38.10%

Market Cap

$545.2K

Sector

Ancillary

Ancillary Sector Peers

All Ancillary cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
SMGScotts Miracle-Gro$60.96+0.96%$3.54B
TPBTurning Point Brands$90.62+0.69%$1.73B
KERNAkerna Corp$6.27+24.64%$376.3M
LFLYLeafly Holdings$135.50+17.98%$271.0M
AGFYAgrify Corp$47.12+4.71%$94.2M
MAPSWM Technology (Weedmaps)$0.68-7.27%$73.0M
FORAForian Inc$2.05-0.97%$63.7M
GRWGGrowGeneration$1.06-2.75%$63.4M
GRAMFTPCO Holding (The Parent Company)$0.16-12.99%$45.7M
HYFMHydrofarm Holdings$1.19-6.30%$5.6M
GNLNGreenlane Holdings$0.82-1.84%$4.1M

Top Matchups by Market Cap

Companies closest to FinCanna Capital in market capitalization — the most meaningful head-to-head comparisons.

OVATFBiotech

Ovation Science

MCap: $623.3K

$0.020.00%
Compare
AYURFLP

Ayurcann Holdings

MCap: $389.4K

$0.000.00%
Compare
ACRHFMSO

Acreage Holdings

MCap: $323.6K

$0.00-4.76%
Compare
CSUIInternational

Cannabis Suisse Corp

MCap: $848.4K

$0.010.00%
Compare
GBHPFCBD

Global Hemp Group

MCap: $178.0K

$0.010.00%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the Ancillary sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $10.99B

$178.55-1.66%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.48B

$52.66-2.34%
Compare
TCNNFMSO

Trulieve Cannabis

MCap: $1.22B

$6.40+4.92%
Compare

Comparing FNNZF in the Cannabis Market

FinCanna Capital (FNNZF) is a Ancillary-sector cannabis company trading at $0.00 per share with a market capitalization of $545.2K. Among its Ancillary peers, FNNZF ranks #12 by market cap, with trailing twelve-month revenue of $0 and a gross margin of 0.0%. The stock has moved +38.10% in the current session, trading on the OTC exchange.

When comparing FNNZF against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (N/A), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $0). The comparison tables above allow you to evaluate FinCanna Capital relative to 11 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does FNNZF compare to other Ancillary stocks?+
FinCanna Capital has a market cap of $545.2K, placing it among 12 companies in the Ancillary sector. Its price-to-sales ratio is N/A and its gross margin is 0.0%. Use the table above to compare these metrics against every Ancillary peer.
What is FNNZF's biggest competitor?+
By market capitalization, the closest comparable company is Ovation Science (OVATF) with a market cap of $623.3K. Click the compare link to view a full head-to-head analysis.
Is FNNZF overvalued compared to its peers?+
FinCanna Capital trades at a P/S ratio of N/A. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than FNNZF?+
FinCanna Capital has a gross margin of 0.0%. Among its Ancillary peers, 9 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare FNNZF to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside Ancillary. You can click any company to see a full side-by-side comparison with FNNZF covering price, valuation, financials, and growth metrics.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.